UK High Court Finds PMI Heat-not-burn Patent Valid; Rejects BAT Request

Business by Law 360
Apr.19.2023
The High Court of London rejected BAT's application to revoke two heated tobacco technology patents of competitor PMI and found that the patent of PMI's heat-not-burn technology system is valid.
UK High Court Finds PMI Heat-not-burn Patent Valid; Rejects BAT Request

 

On April 18, the High Court in London rejected an application by British American Tobacco (BAT) and its subsidiary Nicoventures to revoke two heated tobacco technology patents of rival Philip Morris (PMI), an ongoing dispute between the two companies. This is the latest ruling in an ongoing patent dispute between the two companies.

 

Judge Finds PMI Technology Patent Valid

 

On April 18, the High Court in London ruled that the patent for PMI's heat-not-burn technology system, which heats tobacco to the point where it is vaporized without burning it, is valid.

 

Associate Justice Michael Tappin KC said the differences between the original global patent application and the resulting European patent were not sufficient grounds for invalidating (PMI's) patents because they did not disclose any "new information (new information)."

 

Judge Tappin also ruled that a (BAT) 1998 patent application, the so-called "Pienemann" patent application, did not describe the same invention as detailed in PMI's two patent claims.

 

The patent disputes in this case mainly focus on two aspects. The first term is the "spray-forming substrate in the unheated upstream part" of the heating system for the heat-not-burn product. The second term is the length-dependent "additional material" of the heating element.

 

According to the judgment, BAT's "Pienemann" patent did not cover the thin film heater in the PMI patent but rather BAT's own "graphite loaded sheath." Accordingly, according to the judgment, two of PMI's patents were ruled valid.

 

The Patent War Between the Two Sides Continues

 

While the (PMI) patent was found valid, the court also said that BAT's "Glo" heated tobacco product did not infringe the patent, thereby avoiding an infringement counterclaim by PMI.

 

The ruling is the latest in an ongoing patent dispute between the two tobacco giants looking to capture the "unheated" tobacco market.

 

It is reported that PMI initially sued BAT and Nicoventures, a subsidiary of BAT that sells non-burn products. PMI claims they infringe several patents it holds for similar technology. This prompted BAT and Nicoventures to file countersuits seeking to invalidate the patents.

 

A spokesman for the BAT welcomed the patent court's non-infringement ruling on the glo product but had no comment on the "Pienemann" invalidation ruling; a PMI representative did not respond to requests for comment.

 

The case, numbered HP-2022-000002, is heard in the High Court of England and Wales.

Reference:

Philip Morris Extinguishes BAT Tobacco Patent Challenge

 

Also read:

US Federal Court Reopens PMI Patent Lawsuit and Revokes Attorney Fee
KT&G Maintains Lead, PMI's Profit up 163%, BAT Korea's Profit Down 12%.

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
The UK’s Vaping Products Duty (VPD), scheduled to take effect in October 2026, is prompting retailers to assess how different vape categories may be affected. UK retailer Vape HQ has estimated potential price changes under the new volume-based tax system, showing that 100ml shortfill e-liquids could see prices rise from around £12.99 to £39.39, a 203% increase, while 2ml prefilled pod vape kits could rise from £5.99 to £6.52, an increase of about 9%. The estimates highlight how a volume-based tax structure creates uneven cost impacts across product categories.
Aug.19
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07